Theranexus Unveiled: Pioneering Neurological Advancements in the Era of AI-Driven Biopharmaceuticals
In the dynamic landscape of artificial intelligence (AI) companies, Theranexus stands out as a beacon of innovation and scientific prowess. Originating from the French Atomic Energy Commission (CEA), Theranexus has evolved into an avant-garde biopharmaceutical company with a singular focus on neurological diseases. What sets Theranexus apart is its pioneering approach in developing drug candidates…